delcath systems inc nasdaqdcth quotes  news  google financecookies help us deliver our services by using our services you agree to our use of cookieslearn moregot itmy accountsearchmapsyoutubeplaynewsgmaildrivecalendargoogletranslatephotosmoreshoppingwalletfinancedocsbooksbloggercontactshangoutskeepeven more from googlesign inhidden fieldssearch financeadobe flash player is required for interactive charts allowfinancedelcath systems incnasdaqdcthadd to portfoliocompanysummarynewsrelated companieshistorical pricesfinancialsmarketsnewsportfoliosstock screenergoogle domestic trendsrecent quotes  daysyou have no recent quoteschg   delcath systems inc  public nasdaqdcth   watch this stock      premarket    jul  am edt   nasdaq realtime data  disclaimer currency in usd range     week    open  vol  avg m mkt cap m pe      divyield      eps  shares m beta  inst own  news relevance date all news for delcath systems inc » subscribe advertisement key stats and ratios q mar   net profit margin   operating margin   ebitd margin   return on average assets   return on average equity   employees   cdp score   screen stocks with similar metrics » address  broadway ste cnew york ny united states  map phone fax website links httpwwwdelcathcom external links analyst estimates  marketwatch sec filings  edgar online major holders  msn money research reports  reuters settings  technicals  link to this view volume delayed by  minsprices are not from all markets sources include six advertisement related companies show most recent quarter most recent annual add or remove columns save changes cancel sector healthcare  industry medical prosthetics more from factset » description delcath systems inc is a latestage clinical development company with early commercial activity in europe focused on cancers of the liver the company is a specialty pharmaceutical and medical device company developing its product melphalan hydrochloride for injection for use with the delcath hepatic delivery system melphalanhds the companys system delivers and filters melphalan hydrochloride which is marketed as a device under the trade name delcath hepatic chemosat delivery system for melphalan chemosat the companys focus is on the execution of the clinical development program cdp in ocular melanoma liver metastases mom intrahepatic cholangiocarncinoma icc hepatocellular carcinoma hcc or primary liver and other cancers that are metastatic to the liver more from reuters » officers and directors roger g stoll phd chairman of the board age  bio  compensation   reuters jennifer k simpson phd president chief executive officer director age  bio  compensation   reuters barbra c keck principal financial officer senior vice president  finance principal accounting officer secretary age  bio  compensation   reuters john purpura executive vice president  regulatory affairs and quality assurance age  bio  compensation   reuters harold s koplewicz md independent director age  bio  compensation   reuters william dodge rueckert independent director age  bio  compensation   reuters marco taglietti md independent director age  bio  compensation   reuters full list on reuters » google finance beta available in hong kong  canada  us  china  ukinformation is provided as is and solely for informational purposes not for trading purposes or advice and may be delayedto see all exchange delays please see disclaimer google  google home  blog  help  report a problem  privacy policy  terms of service stocks index  markets index bulletin starbuckss stock on track to open at month low after q results late thursday » investor alert new york markets open in market snapshot analyst ratings stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aamerican airlines q eps  vs  a year ago athese companies spent over  billion buying back shares while their ceos were dumping them ahealthcare fund managers say a spike in drugs and devices will produce big returns astarbucks on track to open at month low astarbuckss stock tumbles  premarket after q results late thursday aa case for buying the freakin’ dip with amazon as the mooch might now say acan snap fall even more as lockups expire achip stocks are cool again but reality is here awhere to get chipotle queso check out this interactive map aaarons acquires its largest franchisee in allcash deal aexpedia stock price target raised to  from  at piper jaffray aa provocative new analysis suggests you don’t have to take all your antibiotics after all apriceline stock price target raised to  from  at piper jaffray asjw group upgraded to buy from neutral at janney avf corp stock price target raised to  from  at susquehanna financial adollar spins wheels ahead of gdp report expected to show faster clip of growth avf corp upgraded to positive from neutral at susquehanna financial ateradyne upgraded to overweight from sector weight at keybanc capital alogmein upgraded to overweight from sector weight at keybanc capital atwitter stock price target raised to  from  at rbc capital loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stockscountryunited states index  markets index bulletin starbuckss stock on track to open at month low after q results late thursday » investor alert new york markets open in market snapshot analyst ratings stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aamerican airlines q eps  vs  a year ago athese companies spent over  billion buying back shares while their ceos were dumping them ahealthcare fund managers say a spike in drugs and devices will produce big returns astarbucks on track to open at month low astarbuckss stock tumbles  premarket after q results late thursday aa case for buying the freakin’ dip with amazon as the mooch might now say acan snap fall even more as lockups expire achip stocks are cool again but reality is here awhere to get chipotle queso check out this interactive map aaarons acquires its largest franchisee in allcash deal aexpedia stock price target raised to  from  at piper jaffray aa provocative new analysis suggests you don’t have to take all your antibiotics after all apriceline stock price target raised to  from  at piper jaffray asjw group upgraded to buy from neutral at janney avf corp stock price target raised to  from  at susquehanna financial adollar spins wheels ahead of gdp report expected to show faster clip of growth avf corp upgraded to positive from neutral at susquehanna financial ateradyne upgraded to overweight from sector weight at keybanc capital alogmein upgraded to overweight from sector weight at keybanc capital atwitter stock price target raised to  from  at rbc capital loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stocks index  markets index bulletin starbuckss stock on track to open at month low after q results late thursday » investor alert new york markets open in market snapshot analyst ratings stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aamerican airlines q eps  vs  a year ago athese companies spent over  billion buying back shares while their ceos were dumping them ahealthcare fund managers say a spike in drugs and devices will produce big returns astarbucks on track to open at month low astarbuckss stock tumbles  premarket after q results late thursday aa case for buying the freakin’ dip with amazon as the mooch might now say acan snap fall even more as lockups expire achip stocks are cool again but reality is here awhere to get chipotle queso check out this interactive map aaarons acquires its largest franchisee in allcash deal aexpedia stock price target raised to  from  at piper jaffray aa provocative new analysis suggests you don’t have to take all your antibiotics after all apriceline stock price target raised to  from  at piper jaffray asjw group upgraded to buy from neutral at janney avf corp stock price target raised to  from  at susquehanna financial adollar spins wheels ahead of gdp report expected to show faster clip of growth avf corp upgraded to positive from neutral at susquehanna financial ateradyne upgraded to overweight from sector weight at keybanc capital alogmein upgraded to overweight from sector weight at keybanc capital atwitter stock price target raised to  from  at rbc capital loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  dcth stock price  delcath systems inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y djia f    sp f    nasdaq f    gold    silver    crude oil    sp  movers adp  tsco  vz  orly  ca  jci  ffiv  xl  latest newsall times eastern a updated these companies spent over  billion buying back shares while their ceos were dumping them a updated healthcare fund managers say a spike in drugs and devices will produce big returns a starbucks on track to open at month low a starbuckss stock tumbles  premarket after q results late thursday a updated a case for buying the freakin’ dip with amazon as the mooch might now say a updated can snap fall even more as lockups expire a updated chip stocks are cool again but reality is here a updated where to get chipotle queso check out this interactive map a aarons acquires its largest franchisee in allcash deal a expedia stock price target raised to  from  at piper jaffray to be replaced home investing quotes stocks united states dcth overview compare quotes stock screener earnings calendar sectors nasdaq dcth us nasdaq join td ameritrade find a broker delcath systems inc watchlist createdcthalert premarket last updated jul    am edt delayed quote     before hours volume  close chg chg     advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume m  day avg  m open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume m performance  day   month   month  ytd   year  recent news marketwatch other dow jones delcath cuts work force by  jun   at  am et friday’s movers regeneron linkedin may   at  pm et by wallace witkowski delcath systems falls  in premarket oct   at  am et by steve gelsi hot stocks to watch sep   at  am et friday’s top gaining and declining stocks may   at  pm et by val brickates kennedy delcath prices stock offering at  discount may   at  pm et friday’s biggest gaining and declining stocks jan   at  pm et by marketwatch corrected friday’s biggest gaining and declining stocks jan   at  pm et by kate gibson stocks to watch tuesday boeing verizon dec   at  pm et by marketwatch ti cisco edge up mosys slips afterhours dec   at  pm et by benjamin pimentel delcath reports inconclusive results from trial sep   at  pm et friday’s biggest gaining and declining stocks jul   at  pm et by kate gibson tuesday’s biggest gainers and decliners feb   at  pm et by kate gibson delcath clinical data lead drug stocks south feb   at  pm et by val brickates kennedy delcath implodes on fda setback feb   at  am et by val brickates kennedy in focus have the bears arrived nov   at  pm et by lawrence g mcmillan sp  pulls in from the  resistance oct   at  am et by michael ashbaugh market bulls absorb weak sept jobs report oct   at  am et by michael ashbaugh mondays biggest gaining and declining stocks jun   at  pm et by marketwatch thursdays biggest gaining and declining stocks apr   at  pm et by marketwatch stocks to watch forest oil discovery labs xyratex oct   at  am et on the wall street journal cfo moves brooks automation suntech power delcath systems sep   at  pm et on the wall street journal stocks to watch ulta salon gsv capital nxp semiconductors sep   at  am et on the wall street journal stocks to watch linkedin procera delcath may   at  am et on the wall street journal stocks to watch jc penney medley capital corrections corp apr   at  am et on the wall street journal stocks to watch etrade mens wearhouse flotek industries mar   at  am et on the wall street journal stocks to watch zynga mens wearhouse vera bradley dec   at  am et on the wall street journal stocks to watch campbell soup medicis pharma questcor pharma sep   at  am et on the wall street journal stocks to watch frontline verifone systems talbots may   at  am et on the wall street journal stocks to watch netflix hewlettpackard nov   at  am et on the wall street journal stocks to watch citigroup united continental and more jul   at  am et on the wall street journal stocks eke out a gain apr   at  am et on the wall street journal small stock issues end higher jun   at  am et on the wall street journal buying on dip erases nasdaqs early losses jun   at  am et on the wall street journal recent news other news press releases cambridge advisors inc buys vanguard total international stock etf spdr sp dividend  cambridge advisors inc buys vanguard total international stock etf spdr sp dividend visa inc sells the valspar corp johnson controls international plc target corp jul   at  am et on gurufocuscom delcath systems second attempt at shareholder approval for reverse split delcath systems second attempt at shareholder approval for reverse split jul   at  am et on seeking alpha delcath systems share price has risen over  in the past month on no news and is engaged in death spiral financing delcath systems share price has risen over  in the past month on no news and is engaged in death spiral financing jul   at  am et on seeking alpha delcath systems may take off in the near future delcath systems may take off in the near future jul   at  am et on seeking alpha delcath systems offers significant upside for risktolerant investors delcath systems offers significant upside for risktolerant investors jul   at  am et on seeking alpha delcath systems wait for the dust to settle delcath systems wait for the dust to settle jul   at  pm et on seeking alpha delcath continues up move shares ahead  delcath continues up move shares ahead  jun   at  am et on seeking alpha delcath annual meeting postponed until june  to allow more shares to be voted reverse stock split proposed shares ahead  delcath annual meeting postponed until june  to allow more shares to be voted reverse stock split proposed shares ahead  jun   at  pm et on seeking alpha q delcath systems inc q delcath systems inc may   at  am et on edgar online  edg  q k delcath systems dcth presents at th annual roth conference mar   at  pm et on seeking alpha retrospective study shows treatment benefit of php in metastatic ocular melanoma patients delcath up  feb   at  am et on seeking alpha delcath systems dcth investor presentation  slideshow feb   at  am et on seeking alpha delcath to allow holders of convertible debt to temporarily lower conversion price to  until feb  shares ease  jan   at  am et on seeking alpha midstage study of delcath system in type of liver cancer progressing retrospective data sufficient for efficacy signal shares up  jan   at  am et on seeking alpha dryships merrimack tumble into friday’s week low club jan   at  pm et on wallstcom q delcath systems inc nov   at  pm et on edgar online  edg  q k  health care equipment  supplies stocks to sell now oct   at  am et on investorplacecom  health care equipment  supplies stocks to sell now oct   at  am et on investorplacecom delcath prices stock offering at  shares off  sep   at  am et on seeking alpha q delcath systems inc aug   at  pm et on edgar online  edg  q k technical reports on drug delivery equities  petmed express adamis pharma delcath systems and alkermes technical reports on drug delivery equities  petmed express adamis pharma delcath systems and alkermes jul   at  am et on pr newswire  prf delcath systems inc announces adjournment of annual meeting meeting scheduled to reconvene on june  delcath systems inc announces adjournment of annual meeting meeting scheduled to reconvene on june  jun   at  pm et on globenewswire research reports coverage on drug delivery stocks  valeant pharma delcath systems alkermes and adamis pharma research reports coverage on drug delivery stocks  valeant pharma delcath systems alkermes and adamis pharma may   at  am et on pr newswire  prf delcath announces first quarter  financial results delcath announces first quarter  financial results may   at  am et on globenewswire delcath issues letter to stockholders apr   at  am et on globenewswire spire southampton hospital in uk celebrating over  chemosat treatments apr   at  am et on globenewswire research reports initiation on healthcare stocks  valeant pharma delcath systems alkermes and amphastar pharma apr   at  am et on pr newswire  prf delcath announces  financial results mar   at  am et on globenewswire delcath announces special protocol assessment agreement with fda for pivotal trial with melphalanhds in intrahepatic cholangiocarcinoma mar   at  am et on globenewswire healthcare stocks on investors radar  delcath systems palatin technologies amag pharma and idexx laboratories mar   at  am et on pr newswire  prf delcath systems to present at roth capital partners th annual growth stock conference on march   mar   at  am et on globenewswire published review shows delcath investigational php doubles overall survival over other targeted liver therapies feb   at  am et on globenewswire analysis from two institutions shows strong tumor response overall survival potential of delcath investigational php therapy feb   at  am et on globenewswire delcath systems to present at the nd annual disruptive growth  healthcare conference feb   at  am et on accesswire research reports initiation on healthcare stocks  palatin technologies amag pharma idexx labs and delcath systems feb   at  am et on pr newswire  prf delcath systems to present at the noblecon  noble capital markets thirteenth annual investor conference on january   jan   at  am et on pr newswire  prf new outcomes data using delcaths melphalanhds to treat unresectable metastatic ocular melanoma to the liver accepted for oral presentation at regional cancer therapies symposium jan   at  am et on pr newswire  prf delcath announces ongoing patient treatment and data collection in intrahepatic cholangiocarcinoma study cohort jan   at  am et on pr newswire  prf delcath systems to present at the th annual ld micro main event nov   at  am et on accesswire delcath announces third quarter financial results nov   at  am et on pr newswire  prf delcath systems inc delcath systems inc is a pharmaceutical and medical device company which focuses on oncology and liver cancer therapy it develops and commercializes melphalan hydrochloride for injection which is a proprietary product for use with the delcath hepatic delivery system it is designed to administer concentrated regional chemotherapy to the liver the company was founded on august   and is headquartered in new york ny see full profile benzingas top initiations mar   at  am et on benzingacom competitors name chg  market cap icu medical inc  b merit medical systems inc  b angiodynamics inc  m insulet corp  b baxter international inc  b competitor data provided by partner content trending tickers powered by amzn  spy  uvxy  qqq  aapl  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience delcath  about about us about delcath delcath systems inc is a specialty pharmaceutical and medical device company focused on oncology our proprietary productmelphalan hydrochloride for injection for use with the delcath hepatic delivery system melphalanhdsis designed to administer high dose chemotherapy to the liver while controlling the systemic exposure to those agents the companys principal focus is on the treatment of primary and metastatic liver cancers in the united states the melphalanhds system is considered a combination drug and device product and is regulated as a drug by the united states food and drug administration fda the melphalanhds system has not been approved for sale in the united states in europe our proprietary system to deliver and filter melphalan hydrochloride is marketed as a device under the trade name delcath hepatic chemosatâž delivery system for melphalan chemosat in april  we obtained authorization to affix a ce mark for the generation two chemosat system the right to affix the ce mark allows the company to market and sell the chemosat system in europe the company has commenced a global phase  clinical trial in europe to investigate melphalanhds system for primary liver cancer and is initiating plans to evaluate intrahepatic cholangiocarcinoma history delcath has spent many years researching ways to administer ultrahigh doses of established chemotherapeutic drugs to the liver see all history management team barbra c keckchief financial officer meet the rest of the management team medical advisory board jeff geschwind mdjohns hopkins university school of medicine meet the rest of the medical advisory board related links board of directors corporate governance delcath  about about us about delcath delcath systems inc is a specialty pharmaceutical and medical device company focused on oncology our proprietary productmelphalan hydrochloride for injection for use with the delcath hepatic delivery system melphalanhdsis designed to administer high dose chemotherapy to the liver while controlling the systemic exposure to those agents the companys principal focus is on the treatment of primary and metastatic liver cancers in the united states the melphalanhds system is considered a combination drug and device product and is regulated as a drug by the united states food and drug administration fda the melphalanhds system has not been approved for sale in the united states in europe our proprietary system to deliver and filter melphalan hydrochloride is marketed as a device under the trade name delcath hepatic chemosatâž delivery system for melphalan chemosat in april  we obtained authorization to affix a ce mark for the generation two chemosat system the right to affix the ce mark allows the company to market and sell the chemosat system in europe the company has commenced a global phase  clinical trial in europe to investigate melphalanhds system for primary liver cancer and is initiating plans to evaluate intrahepatic cholangiocarcinoma history delcath has spent many years researching ways to administer ultrahigh doses of established chemotherapeutic drugs to the liver see all history management team barbra c keckchief financial officer meet the rest of the management team medical advisory board jeff geschwind mdjohns hopkins university school of medicine meet the rest of the medical advisory board related links board of directors corporate governance dcth stock price  delcath systems inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin starbuckss stock on track to open at month low after q results late thursday bulletin us europe asia fx rates futures range d d m m m y y djia f    sp f    nasdaq f    gold    silver    crude oil    sp  movers adp  tsco  vz  orly  ca  jci  ffiv  xl  latest newsall times eastern a american airlines q eps  vs  a year ago a updated these companies spent over  billion buying back shares while their ceos were dumping them a updated healthcare fund managers say a spike in drugs and devices will produce big returns a starbucks on track to open at month low a starbuckss stock tumbles  premarket after q results late thursday a updated a case for buying the freakin’ dip with amazon as the mooch might now say a updated can snap fall even more as lockups expire a updated chip stocks are cool again but reality is here a updated where to get chipotle queso check out this interactive map a aarons acquires its largest franchisee in allcash deal to be replaced home investing quotes stocks united states dcth overview compare quotes stock screener earnings calendar sectors nasdaq dcth us nasdaq join td ameritrade find a broker delcath systems inc watchlist createdcthalert premarket last updated jul    am edt delayed quote     before hours volume  close chg chg     advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume m  day avg  m open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume m performance  day   month   month  ytd   year  recent news marketwatch other dow jones delcath cuts work force by  jun   at  am et friday’s movers regeneron linkedin may   at  pm et by wallace witkowski delcath systems falls  in premarket oct   at  am et by steve gelsi hot stocks to watch sep   at  am et friday’s top gaining and declining stocks may   at  pm et by val brickates kennedy delcath prices stock offering at  discount may   at  pm et friday’s biggest gaining and declining stocks jan   at  pm et by marketwatch corrected friday’s biggest gaining and declining stocks jan   at  pm et by kate gibson stocks to watch tuesday boeing verizon dec   at  pm et by marketwatch ti cisco edge up mosys slips afterhours dec   at  pm et by benjamin pimentel delcath reports inconclusive results from trial sep   at  pm et friday’s biggest gaining and declining stocks jul   at  pm et by kate gibson tuesday’s biggest gainers and decliners feb   at  pm et by kate gibson delcath clinical data lead drug stocks south feb   at  pm et by val brickates kennedy delcath implodes on fda setback feb   at  am et by val brickates kennedy in focus have the bears arrived nov   at  pm et by lawrence g mcmillan sp  pulls in from the  resistance oct   at  am et by michael ashbaugh market bulls absorb weak sept jobs report oct   at  am et by michael ashbaugh mondays biggest gaining and declining stocks jun   at  pm et by marketwatch thursdays biggest gaining and declining stocks apr   at  pm et by marketwatch stocks to watch forest oil discovery labs xyratex oct   at  am et on the wall street journal cfo moves brooks automation suntech power delcath systems sep   at  pm et on the wall street journal stocks to watch ulta salon gsv capital nxp semiconductors sep   at  am et on the wall street journal stocks to watch linkedin procera delcath may   at  am et on the wall street journal stocks to watch jc penney medley capital corrections corp apr   at  am et on the wall street journal stocks to watch etrade mens wearhouse flotek industries mar   at  am et on the wall street journal stocks to watch zynga mens wearhouse vera bradley dec   at  am et on the wall street journal stocks to watch campbell soup medicis pharma questcor pharma sep   at  am et on the wall street journal stocks to watch frontline verifone systems talbots may   at  am et on the wall street journal stocks to watch netflix hewlettpackard nov   at  am et on the wall street journal stocks to watch citigroup united continental and more jul   at  am et on the wall street journal stocks eke out a gain apr   at  am et on the wall street journal small stock issues end higher jun   at  am et on the wall street journal buying on dip erases nasdaqs early losses jun   at  am et on the wall street journal recent news other news press releases cambridge advisors inc buys vanguard total international stock etf spdr sp dividend  cambridge advisors inc buys vanguard total international stock etf spdr sp dividend visa inc sells the valspar corp johnson controls international plc target corp jul   at  am et on gurufocuscom delcath systems second attempt at shareholder approval for reverse split delcath systems second attempt at shareholder approval for reverse split jul   at  am et on seeking alpha delcath systems share price has risen over  in the past month on no news and is engaged in death spiral financing delcath systems share price has risen over  in the past month on no news and is engaged in death spiral financing jul   at  am et on seeking alpha delcath systems may take off in the near future delcath systems may take off in the near future jul   at  am et on seeking alpha delcath systems offers significant upside for risktolerant investors delcath systems offers significant upside for risktolerant investors jul   at  am et on seeking alpha delcath systems wait for the dust to settle delcath systems wait for the dust to settle jul   at  pm et on seeking alpha delcath continues up move shares ahead  delcath continues up move shares ahead  jun   at  am et on seeking alpha delcath annual meeting postponed until june  to allow more shares to be voted reverse stock split proposed shares ahead  delcath annual meeting postponed until june  to allow more shares to be voted reverse stock split proposed shares ahead  jun   at  pm et on seeking alpha q delcath systems inc q delcath systems inc may   at  am et on edgar online  edg  q k delcath systems dcth presents at th annual roth conference mar   at  pm et on seeking alpha retrospective study shows treatment benefit of php in metastatic ocular melanoma patients delcath up  feb   at  am et on seeking alpha delcath systems dcth investor presentation  slideshow feb   at  am et on seeking alpha delcath to allow holders of convertible debt to temporarily lower conversion price to  until feb  shares ease  jan   at  am et on seeking alpha midstage study of delcath system in type of liver cancer progressing retrospective data sufficient for efficacy signal shares up  jan   at  am et on seeking alpha dryships merrimack tumble into friday’s week low club jan   at  pm et on wallstcom q delcath systems inc nov   at  pm et on edgar online  edg  q k  health care equipment  supplies stocks to sell now oct   at  am et on investorplacecom  health care equipment  supplies stocks to sell now oct   at  am et on investorplacecom delcath prices stock offering at  shares off  sep   at  am et on seeking alpha q delcath systems inc aug   at  pm et on edgar online  edg  q k technical reports on drug delivery equities  petmed express adamis pharma delcath systems and alkermes technical reports on drug delivery equities  petmed express adamis pharma delcath systems and alkermes jul   at  am et on pr newswire  prf delcath systems inc announces adjournment of annual meeting meeting scheduled to reconvene on june  delcath systems inc announces adjournment of annual meeting meeting scheduled to reconvene on june  jun   at  pm et on globenewswire research reports coverage on drug delivery stocks  valeant pharma delcath systems alkermes and adamis pharma research reports coverage on drug delivery stocks  valeant pharma delcath systems alkermes and adamis pharma may   at  am et on pr newswire  prf delcath announces first quarter  financial results delcath announces first quarter  financial results may   at  am et on globenewswire delcath issues letter to stockholders apr   at  am et on globenewswire spire southampton hospital in uk celebrating over  chemosat treatments apr   at  am et on globenewswire research reports initiation on healthcare stocks  valeant pharma delcath systems alkermes and amphastar pharma apr   at  am et on pr newswire  prf delcath announces  financial results mar   at  am et on globenewswire delcath announces special protocol assessment agreement with fda for pivotal trial with melphalanhds in intrahepatic cholangiocarcinoma mar   at  am et on globenewswire healthcare stocks on investors radar  delcath systems palatin technologies amag pharma and idexx laboratories mar   at  am et on pr newswire  prf delcath systems to present at roth capital partners th annual growth stock conference on march   mar   at  am et on globenewswire published review shows delcath investigational php doubles overall survival over other targeted liver therapies feb   at  am et on globenewswire analysis from two institutions shows strong tumor response overall survival potential of delcath investigational php therapy feb   at  am et on globenewswire delcath systems to present at the nd annual disruptive growth  healthcare conference feb   at  am et on accesswire research reports initiation on healthcare stocks  palatin technologies amag pharma idexx labs and delcath systems feb   at  am et on pr newswire  prf delcath systems to present at the noblecon  noble capital markets thirteenth annual investor conference on january   jan   at  am et on pr newswire  prf new outcomes data using delcaths melphalanhds to treat unresectable metastatic ocular melanoma to the liver accepted for oral presentation at regional cancer therapies symposium jan   at  am et on pr newswire  prf delcath announces ongoing patient treatment and data collection in intrahepatic cholangiocarcinoma study cohort jan   at  am et on pr newswire  prf delcath systems to present at the th annual ld micro main event nov   at  am et on accesswire delcath announces third quarter financial results nov   at  am et on pr newswire  prf delcath systems inc delcath systems inc is a pharmaceutical and medical device company which focuses on oncology and liver cancer therapy it develops and commercializes melphalan hydrochloride for injection which is a proprietary product for use with the delcath hepatic delivery system it is designed to administer concentrated regional chemotherapy to the liver the company was founded on august   and is headquartered in new york ny see full profile benzingas top initiations mar   at  am et on benzingacom competitors name chg  market cap icu medical inc  b merit medical systems inc  b angiodynamics inc  m insulet corp  b baxter international inc  b competitor data provided by partner content trending tickers powered by amzn  spy  uvxy  qqq  aapl  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience delcath  technology what is liver directedhigh dose chemotherapy liver directed high dose chemotherapy utilizes percutaneous hepatic perfusion php to deliver concentrated doses of a chemotherapeutic agent directly to the liver get the facts isolation infusion hemofiltration liver directed high dose chemotherapy is performed by a minimally invasive procedure see how it works clinical history delcath has supported the development of chemosaturation therapy through a robust clinical research program find out more pipeline delcath is always innovating a number of clinical trials are planned to further study liver directed high dose chemotherapy for treatment in cancers in the liver such as ocular melanoma hepatocellular carcinoma neuroendocrine tumors and colorectal cancer learn more about the technology see how it works delcath  home focused on liver directedhighdose chemotherapy learn more available in europe delcathâs visit wwwchemosatcom   our technology â  what is liver directed highdose chemotherapy see all technology  products clinical research learn about our research program review the data from our published clinical trials more about our clinical research program congresses  events congresses and events british society of interventional radiology november   see all news  events clinical bibliography phase i study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies browse our clinical bibliography investor events  webcasts investor events and webcasts delcath systems inc at th annual ld micro main event december   delcath systems inc at dawson james securities growth stock conference october   see all investor events and webcasts featured news delcath featured in microcap review latest news november   delcath systems to present at the th annual ld micro main event november   delcath announces third quarter financial results see all news  events careers delcath never stops looking for talented people to add to our team click here to send us your resume see all careers newsletter signup enter your email address to receive company news and updates delivered right to your inbox if you are a human and are seeing this field please leave it blank delcath  home focused on liver directedhighdose chemotherapy learn more available in europe delcathâs visit wwwchemosatcom   our technology â  what is liver directed highdose chemotherapy see all technology  products clinical research learn about our research program review the data from our published clinical trials more about our clinical research program congresses  events congresses and events british society of interventional radiology november   see all news  events clinical bibliography phase i study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies browse our clinical bibliography investor events  webcasts investor events and webcasts delcath systems inc at roth capital partners th annual growth stock conference march   delcath systems inc at nd annual disruptive growth  healthcare conference february   see all investor events and webcasts featured news delcath featured in microcap review latest news june   delcath systems inc announces adjournment of annual meeting meeting scheduled to reconvene on june  may   delcath announces first quarter  financial results see all news  events careers delcath never stops looking for talented people to add to our team click here to send us your resume see all careers newsletter signup enter your email address to receive company news and updates delivered right to your inbox if you are a human and are seeing this field please leave it blank microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft data dumps    freebase api deprecated    google developers freebase api deprecated all products sign in send feedback hey there are you maybe looking for firebase instead data dumps the freebase api will be completely shutdown on aug   this page provides access to the last available data dump read more data dumps are a downloadable version of the data in freebase they constitute a snapshot of the data stored in freebase and the schema that structures it and are provided under the same ccby license the freebasewikidata mappings are provided under the cc license freebase triples freebase deleted triples freebasewikidata mappings license citing freebase triples this dataset contains every fact currently in freebase total triples  billion updated weekly data format ntriples rdf license ccby  gb gzip gb uncompressed download the rdf data is serialized using the ntriples format encoded as utf text and compressed with gzip rdf httprdffreebasecomnsgvjzynm httprdffreebasecomnsmeasurementunitdatedpercentagedate httpwwwworgxmlschemagyearmonth  httprdffreebasecomnsgvjzynm httprdffreebasecomnsmeasurementunitdatedpercentagesource httprdffreebasecomnsgxgfm  httprdffreebasecomnsgvjzynm httprdffreebasecomnstypeobjecttype httprdffreebasecomnsmeasurementunitdatedpercentage  httprdffreebasecomnsgvjzynm httprdffreebasecomnsmeasurementunitdatedpercentagerate   httprdffreebasecomnsgvjzynm httpwwwworgrdfsyntaxnstype httprdffreebasecomnsmeasurementunitdatedpercentage  if youre writing your own code to parse the rdf dumps its often more efficient to read directly from gzip file rather than extracting the data first and then processing the uncompressed data subject predicate object  note in freebase objects have mids that look like mrkqx in rdf those mids become mrkqx likewise freebase schema like commontopic are written as commontopic the subject is the id of a freebase object it can be a freebase mid ex mrkqx for topics and cvts or a humanreadable id ex commontopic for schema the predicate is always a humanreadable id for a freebase property or a property from a standard rdf vocabulary like rdfs freebase foreign key namespaces are also used as predicates to make it easier to look up keys by namespace the object field may contain a freebase mid for an object or a humanreadable id for schema from freebase or other rdf vocabularies it may also include literal values like strings booleans and numeric values topic descriptions often contain newlines in order to make each triple fit on one line we have escaped newlines with n freebase deleted triples we also provide a dump of triples that have been deleted from freebase over time this is a onetime dump through march  in the future we might consider providing periodic updates of recently deleted triples but at the moment we have no specific timeframe for doing so and are only providing this onetime dump the dump is distributed as a targz file gb compressed gb uncompressed it contains  deleted triples in  files there is no particular meaning to the individual files it is just easier to manipulate several smaller files than one huge file thanks to chun how tan and john giannandrea for making this data release possible total triples  million updated june   data format csv license ccby  gb gzip gb uncompressed download the data format is essentially csv with one important caveat the object field may contain any characters including commas as well as any other reasonable delimiters you could think of however all the other fields are guaranteed not to contain commas so the data can still be parsed unambiguously the columns in the dataset are defined as creationtimestamp unix epoch time in milliseconds creator deletiontimestamp unix epoch time in milliseconds deletor subject mid predicate mid object midliteral languagecode csv usermwclwikipediaenusermwclwikipediaenmrtypeobjectkeywikipediaenben usermwclmusicbrainzuserturtlewaxbotmnncpzmusicrecordingartistmvbfmen usermwclimagesusergardeningbotmwmcommonimagesizemklyen usermwclmusicbrainzusermbzpipelinemergebotmfvvltypeobjecttypecommontopicen usermwclimagesusergardeningbotmxsczcommonlicensedobjectlicensemxben usercontentadministratorusergardeningbotmgkbytypeobjecttypetypecontenten usermwclimagesusergardeningbotmhcommontopicimagemcsen usermwclchefmozuserdeletebotmzcztypeobjectnamela casa rosa mexican restauranten freebasewikidata mappings the data has been created based on the wikidatadump of october   and contains only those links that have at least two common wikipedialinks and not a single disagreeing wikipedialink furthermore the lines are sorted by the number of common wikipedialinks although in turtle this does not really matter total triples m updated october   data format ntriples rdf license cc  mb gzip mb uncompressed download the rdf data is serialized using the ntriples format encoded as utf text and compressed with gzip rdf httprdffreebasecomnsmj httpwwwworgowlsameas httpwwwwikidataorgentityq  httprdffreebasecomnsmnrg httpwwwworgowlsameas httpwwwwikidataorgentityq  httprdffreebasecomnsmjgd httpwwwworgowlsameas httpwwwwikidataorgentityq  httprdffreebasecomnsmd httpwwwworgowlsameas httpwwwwikidataorgentityq  httprdffreebasecomnsmgd httpwwwworgowlsameas httpwwwwikidataorgentityq  license freebase data dumps are provided free of charge for any purpose with regular updates by google they are distributed like freebase itself under the creative commons attribution aka ccby and use is subject to the terms of service the freebasewikidata id mappings are provided under cc and can be used without restrictions citing if youd like to cite these data dumps in a publication you may use google freebase data dumps httpsdevelopersgooglecomfreebasedata month day year or as bibtex bibtex misc newslatestcompanyusdcth marketwatch news on dcth delcath cuts work force by   am june    marketwatchcom friday’s movers regeneron linkedin  pm may    wallace witkowski delcath systems falls  in premarket  am oct    steve gelsi hot stocks to watch  am sept    marketwatchcom friday’s top gaining and declining stocks  pm may    val brickates kennedy delcath prices stock offering at  discount  pm may    marketwatchcom friday’s biggest gaining and declining stocks  pm jan    marketwatch friday’s biggest gaining and declining stocks  pm jan    kate gibson stocks to watch tuesday boeing verizon  pm dec    marketwatch ti cisco edge up mosys slips afterhours  pm dec    benjamin pimentel delcath reports inconclusive results from trial  pm sept    marketwatchcom friday’s biggest gaining and declining stocks  pm july    kate gibson tuesday’s biggest gainers and decliners  pm feb    kate gibson delcath clinical data lead drug stocks south  pm feb    val brickates kennedy delcath implodes on fda setback  am feb    val brickates kennedy in focus have the bears arrived  pm nov    lawrence g mcmillan sp  pulls in from the  resistance  am oct    michael ashbaugh market bulls absorb weak sept jobs report  am oct    michael ashbaugh mondays biggest gaining and declining stocks  pm june    marketwatch thursdays biggest gaining and declining stocks  pm april    marketwatch loading more headlines newsnonmarketwatchcompanyusdcth other news on dcth cambridge advisors inc buys vanguard total international stock etf spdr sp dividend   am july    gurufocuscom delcath systems second attempt at shareholder approval for reverse split  am july    seeking alpha delcath systems share price has risen over  in the past month on no news and is engaged in death spiral financing  am july    seeking alpha delcath systems may take off in the near future  am july    seeking alpha delcath systems offers significant upside for risktolerant investors  am july    seeking alpha delcath systems wait for the dust to settle  pm july    seeking alpha delcath continues up move shares ahead   am june    seeking alpha delcath annual meeting postponed until june  to allow more shares to be voted reverse stock split proposed shares ahead   pm june    seeking alpha q delcath systems inc  am may    edgar online  edg  q k delcath systems dcth presents at th annual roth conference  pm march    seeking alpha retrospective study shows treatment benefit of php in metastatic ocular melanoma patients delcath up   pm feb    seeking alpha delcath systems dcth investor presentation  slideshow  am feb    seeking alpha delcath to allow holders of convertible debt to temporarily lower conversion price to  until feb  shares ease   am jan    seeking alpha midstage study of delcath system in type of liver cancer progressing retrospective data sufficient for efficacy signal shares up   pm jan    seeking alpha dryships merrimack tumble into friday’s week low club  pm jan    wallstcom q delcath systems inc  pm nov    edgar online  edg  q k  health care equipment  supplies stocks to sell now  am oct    investorplacecom  health care equipment  supplies stocks to sell now  am oct    investorplacecom delcath prices stock offering at  shares off   am sept    seeking alpha q delcath systems inc  pm aug    edgar online  edg  q k loading more headlines at a glance delcath systems inc  broadway suite c new york new york  phone   industry medical equipmentsupplies sector health carelife sciences fiscal yearend  view sec filings revenue m net income m  sales growth  employees  annual report for dcth newspressreleasecompanyusdcth press releases on dcth technical reports on drug delivery equities  petmed express adamis pharma delcath systems and alkermes  am july    pr newswire  prf delcath systems inc announces adjournment of annual meeting meeting scheduled to reconvene on june   pm june    globenewswire research reports coverage on drug delivery stocks  valeant pharma delcath systems alkermes and adamis pharma  am may    pr newswire  prf delcath announces first quarter  financial results  am may    globenewswire delcath issues letter to stockholders  am april    globenewswire spire southampton hospital in uk celebrating over  chemosat treatments  am april    globenewswire research reports initiation on healthcare stocks  valeant pharma delcath systems alkermes and amphastar pharma  am april    pr newswire  prf delcath announces  financial results  am march    globenewswire delcath announces special protocol assessment agreement with fda for pivotal trial with melphalanhds in intrahepatic cholangiocarcinoma  am march    globenewswire healthcare stocks on investors radar  delcath systems palatin technologies amag pharma and idexx laboratories  am march    pr newswire  prf delcath systems to present at roth capital partners th annual growth stock conference on march    am march    globenewswire published review shows delcath investigational php doubles overall survival over other targeted liver therapies  am feb    globenewswire analysis from two institutions shows strong tumor response overall survival potential of delcath investigational php therapy  am feb    globenewswire delcath systems to present at the nd annual disruptive growth  healthcare conference  am feb    accesswire research reports initiation on healthcare stocks  palatin technologies amag pharma idexx labs and delcath systems  am feb    pr newswire  prf delcath systems to present at the noblecon  noble capital markets thirteenth annual investor conference on january    am jan    pr newswire  prf new outcomes data using delcaths melphalanhds to treat unresectable metastatic ocular melanoma to the liver accepted for oral presentation at regional cancer therapies symposium  am jan    pr newswire  prf delcath announces ongoing patient treatment and data collection in intrahepatic cholangiocarcinoma study cohort  am jan    pr newswire  prf delcath systems to present at the th annual ld micro main event  am nov    accesswire delcath announces third quarter financial results  am nov    pr newswire  prf loading more headlines trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite tlt quoteszigmancomposite jnug x powered by log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aamerican airlines q eps  vs  a year ago athese companies spent over  billion buying back shares while their ceos were dumping them ahealthcare fund managers say a spike in drugs and devices will produce big returns astarbucks on track to open at month low astarbuckss stock tumbles  premarket after q results late thursday aa case for buying the freakin’ dip with amazon as the mooch might now say acan snap fall even more as lockups expire achip stocks are cool again but reality is here awhere to get chipotle queso check out this interactive map aaarons acquires its largest franchisee in allcash deal aexpedia stock price target raised to  from  at piper jaffray aa provocative new analysis suggests you don’t have to take all your antibiotics after all apriceline stock price target raised to  from  at piper jaffray asjw group upgraded to buy from neutral at janney avf corp stock price target raised to  from  at susquehanna financial adollar spins wheels ahead of gdp report expected to show faster clip of growth avf corp upgraded to positive from neutral at susquehanna financial ateradyne upgraded to overweight from sector weight at keybanc capital alogmein upgraded to overweight from sector weight at keybanc capital atwitter stock price target raised to  from  at rbc capital loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  flashratings  contact us facebook autocomplete demo post a rating  month price target   trending sign up log in contact flashratings your emotional state excited confused worried upset panicked angry flashratings  principles facebook autocomplete demo post a rating  month price target   trending sign up log in flashratings principles  flashratings mission is to provide you  the investor  with as much honest and professional research on your investments as possible  we believe its much better to get a multitude of credible opinions on an investment than to arbitrarily follow any single advisor  be it your banker a friend or a tv pundit  flashratings does not provide advice our job is to accurately and objectively report on analysts credible research and opinions the only advice flashratings will ever give you is to absorb as much fundamental research and different opinions as possible and make your own decisions  flashratings favors covering analysts with proven track records but will cover all analysts as long as their research is honest and professional sign up » flashratings  privacy facebook autocomplete demo post a rating  month price target   trending sign up log in privacy flashratings takes the privacy of its users seriously we are committed to safeguarding the privacy of our users while providing a personalised and valuable service this privacy policy statement explains the data processing practices of flashratingscom if you have any requests concerning your personal information or any queries with regard to these practices please contact us here  flashratings collects personal information when you register or when you provide such information voluntarily  we use cookies and other technologies to find out how you use flashratings  flashratings accesses information automatically when you visit our site this information includes url ipaddress browsertype language as well as date and time of your visit  we dont pass on personal information to any third party beyond other flashratings users as specified above without your explicit approval  only summarized depersonalized information is provided to third parties  personal information is used for providing services requested by the user including services with personalized content  additionally we use your personal information for internal research in order to improve your online experience as well as our technologies and services terms of use by using this website you agree to the following terms of use the content on this site including news quotes data and other information is provided by flashratings inc and its third party content providers for your personal information only and is not intended for trading purposes content on this site is not appropriate for the purposes of making a decision to carry out a transaction or trade nor does it provide any form of advice investment tax legal amounting to investment advice or make any recommendations regarding particular financial instruments investments or products neither flashratings inc nor its third party content providers shall be liable for any errors inaccuracies or delays in content or for any actions taken in reliance thereon flashratings inc expressly disclaims all warranties expressed or implied as to the accuracy of any the content provided or as to the fitness of the information for any purpose although flashratings inc makes reasonable efforts to obtain reliable content from third parties flashratings inc does not guarantee the accuracy of or endorse the views or opinions given by any third party content provider this site may point to other internet sites that may be of interest to you however flashratings inc does not endorse or take responsibility for the content on such other sites facebook autocomplete demo post a rating  month price target   home trending sign up log in analyst ranking   name measured ratings sucess rate avg return  mizuho      credit suisse      jefferies      cantor fitzgerald      bank of america merrill lynch      jmp securities      goldman sachs      raymond james      fbr capital markets      william blair     delcath systems inc nasdaqdcth files an k other events  traders log in email password remember forgot password  become a member for free sign up sign up new membersign up for free new customerdiscover our portfolios united states united kingdom france deutschland schweiz de suisse fr settings dynamic quotes  offon markets equities north americaeuropeasiaoceaniamiddle east» more equities indexes dow jonessp nasdaq tsx compftse » more indexes currency  forex eur  usdgbp  usdusd  jpyusd  cadaud  usd» more currencies commodities goldcrude oil wticrude oil brentsilverplatinum» more commodities news latest news companiesmarketseconomycurrency  forexcommoditiesinterest ratesbusiness leadersfinancial calendareconomic calendar listed company analyst recorumorsiposcapital markets transactionsnew contractsprofits warningsappointmentspress releaseseventscorporate actions sector news energybasic materialsindustrialsconsumer cyclicalconsumer noncyclicalfinancialshealthcaretechnologytelecommunications servicesutilities analysis all analysiscommentariesindex analysisstock trading strategiescommodity analysisforex analysis stock picks all stock picks portfolios my portfolio virtual portfolios traders portfolios european portfoliousa portfolioasian portfolio screeners market screener homefundamental analyse top investor ratingtop trading ratingtop consensusgrowth stocksyield stockslow valuations technical analysis oversold stocksoverbought stocksclose to resistancesclose to supportsaccumulation phasemost volatile stocks watchlists my watchlists watchlists top lists yield stocksgrowth stocksundervalued stocks top  flop top news most read newshot news top fundamentals top capitalizationtop yieldtop pertop consensustop fundamentals top technicals top rsiunusual volumestop gapstop stim top movers top usatop canadatop uktop germanytop europetop asia tools market screenerdynamic chartfinancial calendareconomic calendarsector researchcurrency converter our services premium accessdiscover our services traders homepage    equities    nasdaq    delcath systems inc    dcth delcath systems inc dcth add to my list    mes dernières consultmost popular manage my lists  delayed     pm  usd     delcath systems  dcth files an k other events  delcath systems  dcth files an k entry into a material definitiv  delcath  offers significant upside for risktolerant investors summaryquoteschartsnewscalendarcompanyfinancials news summarymost relevantall newssector newstweets delcath systems inc nasdaqdcth files an k other events    am edt send by mail  last name  name  from  to  you can enter multiple email addresses separated by commas message  required fields delcath systems inc nasdaqdcth files an k other eventsitem  other events on july  the company issued a letter to stockholders in connection with the definitive schedule a filed with the sec on the same date a copy of the letter to stockholders is attached as exhibit  to this current report on form k and is incorporated into this item  by reference item  financial statements and exhibits the following exhibit is filed herewith d exhibits exhibit letter to stockholders of the company dated july  delcath systems inc exhibitex  ddexhtm ex ex exhibit    july …to view the full exhibit click hereabout delcath systems inc nasdaqdcth delcath systems inc is a latestage clinical development company with early commercial activity in europe focused on cancers of the liver the company is a specialty pharmaceutical and medical device company developing its product melphalan hydrochloride for injection for use with the delcath hepatic delivery system melphalanhds the company’s system delivers and filters melphalan hydrochloride which is marketed as a device under the trade name delcath hepatic chemosat delivery system for melphalan chemosat the company’s focus is on the execution of the clinical development program cdp in ocular melanoma liver metastases mom intrahepatic cholangiocarncinoma icc hepatocellular carcinoma hcc or primary liver and other cancers that are metastatic to the liver the post delcath systems inc nasdaqdcth files an k other events appeared first on market exclusive market exclusive  source market exclusive  latest news on delcath systems inc  delcath systems inc nasdaq  dcth files an k other events  delcath systems inc  other events financial statements and exhibits form   delcath systems inc nasdaq  dcth files an k entry into a material definit  delcath  entry into a material definitive agreement financial statements and e  delcath  offers significant upside for risktolerant investors  delcath systems inc nasdaq  dcth files an k entry into a material definit  delcath systems inc  entry into a material definitive agreement financial st  delcath systems inc nasdaq  dcth files an k entry into a material definit  delcath systems inc  entry into a material definitive agreement financial st  delcath systems inc  submission of matters to a vote of security holders for more news news from seekingalpha  delcath systems second attempt at shareholder approval for reverse split  delcath systems share price has risen over  in the past month on no news  delcath systems may take off in the near future  delcath systems offers significant upside for risktolerant investors  delcath systems  wait for the dust to settle chart delcath systems inc duration  auto  months  months  months  months  year  years  years  years max period  day week fullscreen chart technical analysis trends delcath systems inc short termmidtermlong termtrendsbullishneutralbearish technical analysis income statement evolution please enable javascript in your browsers settings to use dynamic charts more financials managers nametitlejennifer k simpson president chief executive officer  director roger g stoll nonexecutive chairman john purpura executive vice presidentglobal operations barbra c keck secretary chief financial  accounting officer harold s koplewicz independent director more about the company set sector and competitors st jancapitalization m delcath systems inc sonova holding  straumann holding  cochlear limited  insulet corporation  modern dental group ltd more results traderscom marketsnewsanalysisstock picksportfoliosscreenerswatchliststop  floptoolsour servicesabout surperformance sascontact usadvertiselegal informationsabout usstay connected facebooktwitterpartners börse aktien kurse und nachrichtenbest tweets copyright   surperformance all rights reserved slave delcath systems  wikipedia delcath systems from wikipedia the free encyclopedia jump to navigation search delcath systems inc delcath systems inc nasdaq dcth is a publiclytraded specialty pharmaceutical and medical device company that develops percutaneous perfusion technologies for the targeted administration of highdose chemotherapeutic agents to specific organs or regions of the body based in queensbury new york the company has an intellectual property portfolio consisting of  patents worldwide delcaths percutaneous hepatic perfusion php is currently undergoing phase ii and phase iii trials against tumors in the liver delcath has a cooperative research and development agreement crada with the national cancer institute and has received fast track and a special protocol assessment from the food and drug administration for its use of melphalan in treating unresectable liver tumors php also known as the delcath system is tested for the treatment of metastatic melanoma in the liver and for primary liver cancer and metastatic hepatic malignancies from neuroendocrine cancers and adenocarcinomas as well as patients with melanoma who previously received isolated perfusion chemotherapy is usually delivered intravenously although a number of agents can be administered orally eg specialty drugs melphalan trade name alkeran busulfan capecitabine phase iii melanoma trial enrollingedit university of pittsburgh medical center national cancer institute in bethesda maryland albany medical center in albany new york john wayne cancer center in santa monica california moffitt cancer center in tampa florida morristown memorial hospital in morristown new jersey providence cancer center in portland oregon st lukes cancer center of bethlehem pennsylvania swedish medical center in englewood colorado university of maryland medical center in baltimore maryland university of texas medical branch in galveston texas referencesedit  melphalan granted fda orphan drug designation for treatment of cholangiocarcinoma newsmedicalnet  july  retrieved  october    delcath expands phase ii multihistology clinical trial businesswirecom   specialty pharmacy services an overview for oncology practices the journal of hematology oncology pharmacy  july  issn  archived from the original on  october  retrieved  october   external linksedit delcath official website clinical trial number nct at clinicaltrialsgov  metastatic melanoma in the liver clinical trial number nct at clinicaltrialsgov  primary liver cancer and metastatic hepatic malignancies from neuroendocrine cancers and adenocarcinomas pingpank james f phase i study of hepatic arterial melphalan infusion and hepatic venous hemfiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies j clin oncol  seidel geoffrey d part i regional chemotherapy clinical studies in nontraditional clinical settings cjon yahoo finance this oncology article is a stub you can help wikipedia by expanding it v t e this article about a medical pharmaceutical or biotechnological corporation or company is a stub you can help wikipedia by expanding it v t e retrieved from httpsenwikipediaorgwindexphptitledelcathsystemsoldid categories companies listed on nasdaqcancer organizations based in the united stateshepatologycompanies based in new york cityspecialty drugshealth care companies based in new yorkoncology stubsmedical company stubshidden categories all stub articles navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view delcath systems inc dcth  product pipeline analysis  update infowiseguyreportscom     chat with us           us         uk login register home report categories premium reports access to  premium reports aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports report categories aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports publisher knowledgestore countries browse by country browse by continent browse by group  region conferences upcoming conferences seminars conferences upcoming conferences seminars countries browse by country browse by continent browse by group  region news  blog press release blog news  blogs press release blogs faqs about us about our company our team life at wgr careers contact us there are no items currently in your basket there are no items currently in your basket search home all reports delcath systems inc dcth  product pipeline analysis delcath systems inc dcth  product pipeline analysis  update wgr  may  global  pages globaldata description table of content sample report enquiry before buy related reports summarydelcath systems inc delcath is a specialty pharmaceutical and medical device company it specializes in developing percutaneous perfusion technologies for the targeted administration of highdose chemotherapeutic agents to treat primary and metastatic liver cancers delcaths patented drug delivery platform delivers ultrahigh doses of anticancer drugs to the liver while preventing them from entering the patients bloodstream its clinical trial product the delcath percutaneous hepatic perfusion system the delcath php system also known as hepatic chemosaturation therapy allows physicians to deliver ultrahigh doses of anticancer agents to the liver while controlling their systemic exposure delcath is headquartered in new york the usthis report is a source for data analysis and actionable intelligence on the company’s portfolio of pipeline products the report provides key information about the company its major products and brands the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantagescope the report reviews detailed company profile with information on business description key company facts major products and services key competitors key employees locations and subsidiaries and recent developments the report analyzes all pipeline products in development for the company delcath systems inc the report provides pipeline analysis on all pipeline products of the company by equipment type by indication by development stage and by trial status the report covers detailed information on each pipeline product with information on pipeline territory stage of development device class regulatory path indications applications and estimated launch date the report provides detailed description of products in development technical specification and functions the report also covers ongoing clinical trials wherever applicable with information on trial name trial objective sponsor trial design  trial status and phase estimated start and end datereasons to buy develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape design and develop your product development marketing and sales strategies by understanding the competitor portfolio to formulate effective research  development strategies develop marketentry and market expansion strategies exploit inlicensing and outlicensing opportunities by identifying products most likely to ensure a robust return plan mergers and acquisitions effectively by identifying key players of the most promising pipeline  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials stage and of development etc identify understand and capitalize the next highvalue products that your competitor would add in its portfolio table of contents table of contents list of tables list of figures delcath systems inc company snapshot delcath systems inc company overview key information delcath systems inc pipeline products and clinical trials overview delcath systems inc – pipeline analysis overview business description key facts delcath systems inc  major products and services delcath systems inc pipeline products by development stage delcath systems inc pipeline products overview chemotherapy filter chemotherapy filter product overview delcath hepatic chemosat delivery system delcath hepatic chemosat delivery system product overview generation two hepatic chemosat delivery system generation two hepatic chemosat delivery system product overview hepatic chemosat delivery system  doxorubicin hepatic chemosat delivery system  doxorubicin product overview isolation catheter system isolation catheter system product overview delcath systems inc  key competitors delcath systems inc  key employees delcath systems inc  key employee biographies delcath systems inc  locations and subsidiaries head office other locations  subsidiaries recent developments delcath systems inc recent developments may   delcath reports  first quarter results mar   delcath reports  fourth quarter and full year results nov   delcath reports  third quarter results oct   delcath to report third quarter  results on november   oct   delcath systems announces strategic reorganization sep   delcath systems board of directors implements leadership transition plan jul   delcath to report second quarter  results on august   jun   delcath downsizes workforce by  in us jun   law offices of todd m garber announces class action lawsuit against delcath may   delcath reports q  results appendix methodology about globaldata contact us disclaimer list of tables delcath systems inc key facts delcath systems inc pipeline products and clinical trials overview delcath systems inc pipeline products by equipment type delcath systems inc pipeline products by indication delcath systems inc key facts delcath systems inc major products and services delcath systems inc number of pipeline products by development stage delcath systems inc pipeline products summary by development stage chemotherapy filter  product status chemotherapy filter  product description delcath hepatic chemosat delivery system  product status delcath hepatic chemosat delivery system  product description generation two hepatic chemosat delivery system  product status generation two hepatic chemosat delivery system  product description hepatic chemosat delivery system  doxorubicin  product status hepatic chemosat delivery system  doxorubicin  product description isolation catheter system  product status isolation catheter system  product description delcath systems inc key employees delcath systems inc key employee biographies delcath systems inc other locations delcath systems inc subsidiaries list of figures delcath systems inc pipeline products by equipment type delcath systems inc pipeline products by development stage  request a sample report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro do you have any specific field of interest confirm make an enquiry before buying this report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro your enquiry confirm purchase this market research report usd gbp euro yen inr user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  add to cart buy now   email report   sample report   save page   any questions   download information   check discount   download order form   email report   sample report   save page   any questions   download information   check discount   download order form contact us akash anand domain head business development saleswiseguyreportscom     us     uk rishabh arora domain head business development saleswiseguyreportscom  abu koshy domain head business development saleswiseguyreportscom     related reports × tell a friend about this report your name your email friends name friends email your enquiry send delcath  home focused on liver directedhighdose chemotherapy learn more available in europe delcathâs visit wwwchemosatcom   our technology â  what is liver directed highdose chemotherapy see all technology  products clinical research learn about our research program review the data from our published clinical trials more about our clinical research program congresses  events congresses and events british society of interventional radiology november   see all news  events clinical bibliography phase i study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies browse our clinical bibliography investor events  webcasts investor events and webcasts delcath systems inc at roth capital partners th annual growth stock conference march   delcath systems inc at nd annual disruptive growth  healthcare conference february   see all investor events and webcasts featured news delcath featured in microcap review latest news june   delcath systems inc announces adjournment of annual meeting meeting scheduled to reconvene on june  may   delcath announces first quarter  financial results see all news  events careers delcath never stops looking for talented people to add to our team click here to send us your resume see all careers newsletter signup enter your email address to receive company news and updates delivered right to your inbox if you are a human and are seeing this field please leave it blank delcathsystemscom delcath  investors investors how does the technology work stock information dcthnasdaq cm us dollarchange   ▼ volume data as of jul   pmminimum minute delay refresh quote see all stock information related links corporate profile financials stock information news releases sec filings analyst coverage events and presentations corporate governance request information investor faqs events and presentations march    am pt delcath systems inc at roth capital partners th annual growth stock conference see all events and presentations featured news delcath featured in microcap review latest news releases june   delcath systems inc announces adjournment of annual meeting meeting scheduled to reconvene on june  may   delcath announces first quarter  financial results see all news releases receive investor alerts get the latest news trial results financial updates and more sign up get the investor presentation download the latest delcath investor presentation in adobe pdf format here download disclaimer you are about to review presentations reports filings andor other materials regarding delcath systems inc nasdaq dcth that contain timesensitive information the information contained therein is only current as of the date thereof delcath expressly disclaims any obligation to review update or correct these materials after the date thereof delcath may update amend supplement or otherwise alter the information contained in any such materials by subsequent presentations reports filings or other means without notice certain statements made on this web site or in materials accessed in or through this section of our web site are forward–looking statements which are subject to risks and uncertainties and delcaths actual results may differ possibly materially from those indicated in such statements data provided by thomson reuters delcath  about clinical trials about clinical trials clinical trials are the backbone of modern medicine before a new therapeutic can be made available to the general public rigorous tests involving multiple studies on human volunteers are required these studies are referred to as clinical trials and are regulated by the food and drug administration fda in the united states as well as similar regulatory agencies worldwide clinical trials evaluate the efficacy safety andor tolerability of drugs devices and other kinds of medical treatments each clinical trial is designed to answer specific questions about the treatment at the center of the study there are a few different types of clinical trials they are usually divided into four categories or phases the national institutes of health nih define clinical trial phases in the following way phase  researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety determine a safe dosage range and identify side effectsdelcath completed phase  trial phase  the drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety delcath completed multiarm phase  net results presented at esmo  phase  the drug or treatment is given to large groups of people to confirm its effectiveness monitor side effects compare it to commonly used treatments and collect information that will allow the drug or treatment to be used safely delcath completed randomized phase  preliminary results were presented at asco and updated at esmo  phase  studies are done after the drug or treatment has been marketed to gather information on the drug’s effect in various populations and any side effects associated with longterm use expanded access program for patients who cannot participate in a clinical trial of an investigational drug but have a serious disease or condition that may benefit from treatment with the drug fda regulations enable manufacturers of such drugs to provide those patients access to the drug under certain situations known as “expanded access” the intent of expanded access is to provide treatment for a patient’s disease or condition rather than to collect data about the study drug international federation of pharmaceutical manufacturers  associateshttpwwwifpmaorgcenter watchhttpwwwcenterwatchcomclinical study resultshttpwwwclinicalstudyresultsorg trial enrollment information expanded access study of melphalan csphp with delcath system in patients with ocularcutaneous melanoma mets to liver our expanded access program eap in the united states is now open for enrollment learn more disclaimer delcath does not make any claim whatsoever real or implied about the efficacy or safety of any therapy drug system or technique under active research delcath systems inc nasdaqdcth files an k other events  traders log in email password remember forgot password  become a member for free sign up sign up new membersign up for free new customerdiscover our portfolios united states united kingdom france deutschland schweiz de suisse fr settings dynamic quotes  offon markets equities north americaeuropeasiaoceaniamiddle east» more equities indexes dow jonessp nasdaq tsx compftse » more indexes currency  forex eur  usdgbp  usdusd  jpyusd  cadaud  usd» more currencies commodities goldcrude oil wticrude oil brentsilverplatinum» more commodities news latest news companiesmarketseconomycurrency  forexcommoditiesinterest ratesbusiness leadersfinancial calendareconomic calendar listed company analyst recorumorsiposcapital markets transactionsnew contractsprofits warningsappointmentspress releaseseventscorporate actions sector news energybasic materialsindustrialsconsumer cyclicalconsumer noncyclicalfinancialshealthcaretechnologytelecommunications servicesutilities analysis all analysiscommentariesindex analysisstock trading strategiescommodity analysisforex analysis stock picks all stock picks portfolios my portfolio virtual portfolios traders portfolios european portfoliousa portfolioasian portfolio screeners market screener homefundamental analyse top investor ratingtop trading ratingtop consensusgrowth stocksyield stockslow valuations technical analysis oversold stocksoverbought stocksclose to resistancesclose to supportsaccumulation phasemost volatile stocks watchlists my watchlists watchlists top lists yield stocksgrowth stocksundervalued stocks top  flop top news most read newshot news top fundamentals top capitalizationtop yieldtop pertop consensustop fundamentals top technicals top rsiunusual volumestop gapstop stim top movers top usatop canadatop uktop germanytop europetop asia tools market screenerdynamic chartfinancial calendareconomic calendarsector researchcurrency converter our services premium accessdiscover our services traders homepage    equities    nasdaq    delcath systems inc    dcth delcath systems inc dcth add to my list    mes dernières consultmost popular manage my lists  delayed     pm  usd     delcath systems  dcth files an k other events  delcath systems  dcth files an k entry into a material definitiv  delcath  offers significant upside for risktolerant investors summaryquoteschartsnewscalendarcompanyfinancials news summarymost relevantall newssector newstweets delcath systems inc nasdaqdcth files an k other events    am edt send by mail  last name  name  from  to  you can enter multiple email addresses separated by commas message  required fields delcath systems inc nasdaqdcth files an k other eventsitem  other events on july  the company issued a letter to stockholders in connection with the definitive schedule a filed with the sec on the same date a copy of the letter to stockholders is attached as exhibit  to this current report on form k and is incorporated into this item  by reference item  financial statements and exhibits the following exhibit is filed herewith d exhibits exhibit letter to stockholders of the company dated july  delcath systems inc exhibitex  ddexhtm ex ex exhibit    july …to view the full exhibit click hereabout delcath systems inc nasdaqdcth delcath systems inc is a latestage clinical development company with early commercial activity in europe focused on cancers of the liver the company is a specialty pharmaceutical and medical device company developing its product melphalan hydrochloride for injection for use with the delcath hepatic delivery system melphalanhds the company’s system delivers and filters melphalan hydrochloride which is marketed as a device under the trade name delcath hepatic chemosat delivery system for melphalan chemosat the company’s focus is on the execution of the clinical development program cdp in ocular melanoma liver metastases mom intrahepatic cholangiocarncinoma icc hepatocellular carcinoma hcc or primary liver and other cancers that are metastatic to the liver the post delcath systems inc nasdaqdcth files an k other events appeared first on market exclusive market exclusive  source market exclusive  latest news on delcath systems inc  delcath systems inc nasdaq  dcth files an k other events  delcath systems inc  other events financial statements and exhibits form   delcath systems inc nasdaq  dcth files an k entry into a material definit  delcath  entry into a material definitive agreement financial statements and e  delcath  offers significant upside for risktolerant investors  delcath systems inc nasdaq  dcth files an k entry into a material definit  delcath systems inc  entry into a material definitive agreement financial st  delcath systems inc nasdaq  dcth files an k entry into a material definit  delcath systems inc  entry into a material definitive agreement financial st  delcath systems inc  submission of matters to a vote of security holders for more news news from seekingalpha  delcath systems second attempt at shareholder approval for reverse split  delcath systems share price has risen over  in the past month on no news  delcath systems may take off in the near future  delcath systems offers significant upside for risktolerant investors  delcath systems  wait for the dust to settle chart delcath systems inc duration  auto  months  months  months  months  year  years  years  years max period  day week fullscreen chart technical analysis trends delcath systems inc short termmidtermlong termtrendsbullishneutralbearish technical analysis income statement evolution please enable javascript in your browsers settings to use dynamic charts more financials managers nametitlejennifer k simpson president chief executive officer  director roger g stoll nonexecutive chairman john purpura executive vice presidentglobal operations barbra c keck secretary chief financial  accounting officer harold s koplewicz independent director more about the company set sector and competitors st jancapitalization m delcath systems inc sonova holding  straumann holding  cochlear limited  insulet corporation  modern dental group ltd more results traderscom marketsnewsanalysisstock picksportfoliosscreenerswatchliststop  floptoolsour servicesabout surperformance sascontact usadvertiselegal informationsabout usstay connected facebooktwitterpartners börse aktien kurse und nachrichtenbest tweets copyright   surperformance all rights reserved slave